Skip to the page

Data / Medical devices / United States / Acell, Inc.

Acell, Inc.: FDA-registered device maker in Columbia, MD, United States, 15 510(k) clearances

Acell, Inc. is registered with the FDA (registration 3005920706) in Columbia, MD, United States. It lists 8 device types. The FDA files 15 510(k) clearances under its listings, the newest dated July 11, 2024. 2 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3005920706
Address
6640 Eli Whitney Dr Ste 200, Columbia, MD, United States, 21046
Owner or operator
Integra LifeSciences Corporation (9004007)
Roles
Manufacturer, Specification developer
First device listed
March 24, 2017
Registered through
2026
Brand names listed
Cardion" for Pericardial Repair, Cytal Burn Matrix, Cytal Wound Matrix 1-Layer, Cytal Wound Matrix 2-Layer, Cytal Wound Matrix 3-Layer, Cytal Wound Matrix 6-Layer, Cytal® Wound Matrix Cytal® Burn Matrix, Gentrix Surgical Matrix and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
July 11, 2024K241724Cytal® Wound Matrix; Cytal® Burn MatrixKGNSubstantially EquivalentAcell, Inc.accessdata.fda.gov
July 11, 2024K241706MicroMatrix® UBM ParticulateKGNSubstantially EquivalentAcell, Inc.accessdata.fda.gov
September 22, 2023K230980MicroMatrix® FlexKGNSubstantially EquivalentAcell, Inc.accessdata.fda.gov
November 22, 2019K191734MatriStem UBM Pericardial PatchPSQSubstantially EquivalentAcell, Inc.accessdata.fda.gov
October 25, 2019K192725Cytal Wound Matrix 3-LayerKGNSubstantially EquivalentAcell, Inc.accessdata.fda.gov
February 7, 2019K182259Gentrix Surgical Matrix, Gentrix Surgical Matrix HiatalFTMSubstantially EquivalentAcell, Inc.accessdata.fda.gov
October 6, 2017K172399MicroMatrixKGNSubstantially EquivalentAcell, Inc.accessdata.fda.gov
June 8, 2017K170763Gentrix Surgical Matrix Thick; Gentrix Surgical Matrix ExtendFTMSubstantially EquivalentAcell, Inc.accessdata.fda.gov
December 8, 2015K152721Cytal Wound MatrixKGNSubstantially EquivalentAcell, Inc.accessdata.fda.gov
November 19, 2015K150985Medihoney Wound GelFROSubstantially EquivalentDerma Sciences, Inc.accessdata.fda.gov
July 27, 2011K110546MEDIHONEY HYDROGEL SHEET DRESSINGS WITH ACTIVE LEPTOSPERMUM HONEYFROSubstantially EquivalentDerma Sciences, Inc.accessdata.fda.gov
February 22, 2011K101793MEDIHONEY GEL DRESSING WITH ACTIVE MANUKA HONEYFROSubstantially EquivalentDerma Sciences, Inc.accessdata.fda.gov
April 23, 2008K080315DERMA SCIENCES MEDIHONEY DRESSINGS WITH ACTIVE MANUKA HONEYFROSubstantially EquivalentDerma Sciences, Inc.accessdata.fda.gov
November 7, 2007K072956MEDIHONEY PRIMARY DRESSINGS WITH ACTIVE MANUKA HONEYFROSubstantially EquivalentDerma Sciences, Inc.accessdata.fda.gov
July 12, 2007K053095HONEY ALGINATE DRESSINGFROSubstantially EquivalentDerma Sciences Canada, Inc.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
February 14, 201982228Class IITerminatedGentrix Surgical Matrix Thick, 30 x 40cm, Catalog Number PSMT3040, Lot 013948 - Product Usage: Gentrix Surgical Matrix Thick is intended for implantation to reinforce soft tissue where weakness exists in patients requiriThe devices were released from a lot for which one sample failed to meet the company' s tensile strength specification for lot release.accessdata.fda.gov
July 7, 201159291Not yet classifiedTerminatedMatriStem Plastic Surgery Matrix XS Intended for implantation to reinforce tissue where weakness exists in urological, gynecological, and gastrointestinal anatomy, including, but not limited to the following procedures: Surgical mesh for implantation may have elevated endotoxin levels.accessdata.fda.gov

Compare with other makers

Updated July 11, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.